Naphthimidamide Antimicrobial Synthesis via Carbonyldiimidazole Catalysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a growing public health concern due to increasing bacterial resistance to conventional antibiotics, necessitating the development of new antimicrobial agents with potent activity against drug-resistant microorganisms.

Innovation Solution

The synthesis of N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)-2-naphthimidamide using carbonyldiimidazole as a catalyst, which demonstrates anti-microbial activity against various bacterial and fungal strains.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional antibiotics are used to treat bacterial infections, then microbial infections can be treated, but bacterial resistance to these antibiotics increases

Engineering Contradiction:
Improveantimicrobial activityVSAvoidbacterial resistance
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the chemical structure of antimicrobial agents by incorporating heterocyclic nuclei (oxadiazole, imidazole, naphthimidamide) and adjusting functional groups to create compounds with enhanced antimicrobial activity and reduced resistance development. The synthesis methodology employs carbonyldiimidazole catalysis to achieve efficient coupling reactions producing novel derivatives with improved pharmacological properties.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If new antimicrobial agents are developed to combat drug-resistant microorganisms, then antimicrobial activity is improved, but synthesis complexity increases

Engineering Contradiction:
Improveanti-drug-resistant microorganism activityVSAvoidsynthesis process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent utilizes carbonyldiimidazole (CDI) as a catalyst and intermediate reagent to facilitate the coupling reaction between 2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetic acid and N′-hydroxynaphthalene-2-carboximidamide. This intermediary approach simplifies the synthesis process by enabling efficient bond formation under mild conditions, reducing the complexity of multi-step syntheses required for novel antimicrobial compound development.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The compound effectively treats microbial infections by exhibiting high antimicrobial activity against gram-positive and gram-negative bacteria, as well as fungi, providing a potential solution to antibiotic resistance.

Implementation Method 1

The product can be acquired in satisfactory yields using a catalyst, carbonyldiimidazole (CDI), in the reaction of 2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetic acid (1) with N′-hydroxynaphthalene-2-carboximidamide (2) using carbonyldiimidazole (CDI) as a catalyst in acetonitrile

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS11958815B1N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)-2-naphthimidamide as antimicrobial compound
Publication Date: 2024.04.16 KING FAISAL UNIV
  • US11958815B1 patent drawing
  • US11958815B1 patent drawing
  • US11958815B1 patent drawing

AI summary

A N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)-2-naphthimidamide compound, its synthesis, and its use as an anti-microbial agent.